Literature DB >> 24037181

CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression.

Gisela M Vaitaitis, David H Wagner.   

Abstract

CD4(+) T cells expressing CD40 (Th40 cells) constitute a pathogenic T-cell subset that is necessary and sufficient to transfer autoimmune disease. We have previously demonstrated that CD40 signals peripheral Th40 cells to induce RAG1 and RAG2 expression, proteins necessary for the expression of T-cell receptor (TCR), leading to TCR revision. The dependency of TCR expression in the thymus on RAG proteins has long been known. However, despite numerous publications, there is controversy as to whether TCR expression can be altered in the periphery, post-thymic selective pressures. Therefore, a better understanding of TCR expression in primary peripheral cells is needed. We now show that the CD40 protein itself interacts with RAG1 and RAG2 as well as with Ku70 and translocates to the nucleus in Th40 cells. This indicates that the CD40 molecule is closely involved in the mechanism of TCR expression in the periphery. In addition, Fas signals act as a silencing mechanism for CD40-induced RAGs and prevent CD40 translocation to the nucleus. It will be important to further understand the involvement of CD40 in peripheral TCR expression and how TCR revision impacts auto-antigen recognition in order to effectively target and tolerize autoaggressive T cells in autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037181      PMCID: PMC3818448          DOI: 10.1038/cmi.2013.24

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  49 in total

1.  Receptor editing in developing T cells.

Authors:  M A McGargill; J M Derbinski; K A Hogquist
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

Review 2.  Role of costimulatory molecules in autoimmunity.

Authors:  T Kobata; M Azuma; H Yagita; K Okumura
Journal:  Rev Immunogenet       Date:  2000

3.  Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus.

Authors:  Xiaobo Wang; Weiqing Huang; Masahiko Mihara; Jayashree Sinha; Anne Davidson
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

4.  RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.

Authors:  Pau Serra; Abdelaziz Amrani; Bingye Han; Jun Yamanouchi; Shari J Thiessen; Pere Santamaria
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

5.  Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice.

Authors:  S Yu; B Medling; H Yagita; H Braley-Mullen
Journal:  J Autoimmun       Date:  2001-02       Impact factor: 7.094

Review 6.  V(D)J recombination: RAG proteins, repair factors, and regulation.

Authors:  Martin Gellert
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

7.  Receptor revision in peripheral T cells creates a diverse V beta repertoire.

Authors:  C J McMahan; P J Fink
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes.

Authors:  C J Hawkes; N C Schloot; J Marks; S J Willemen; J W Drijfhout; E K Mayer; M R Christie; B O Roep
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.

Authors:  David H Wagner; Gisela Vaitaitis; Richard Sanderson; Michelle Poulin; Cathleen Dobbs; Kathryn Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

10.  Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.

Authors:  H Skärstrand; A Lernmark; F Vaziri-Sani
Journal:  Scand J Immunol       Date:  2013-01       Impact factor: 3.487

View more
  11 in total

Review 1.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

2.  A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.

Authors:  Gisela M Vaitaitis; Martin G Yussman; David H Wagner
Journal:  J Neuroimmunol       Date:  2019-03-21       Impact factor: 3.478

3.  CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter].

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2019-07-08       Impact factor: 10.122

4.  CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.

Authors:  Gisela M Vaitaitis; Dan M Waid; Martin G Yussman; David H Wagner
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

5.  Platelets promote allergic asthma through the expression of CD154.

Authors:  Jun Tian; Tianyi Zhu; Juan Liu; Zhenhong Guo; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

6.  Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor.

Authors:  Gisela M Vaitaitis; Marynette Rihanek; Aimon K Alkanani; Dan M Waid; Peter A Gottlieb; David H Wagner
Journal:  J Clin Endocrinol Metab       Date:  2019-05-07       Impact factor: 5.958

7.  A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2014-08-08       Impact factor: 10.122

8.  Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.

Authors:  Dan M Waid; Teri Schreiner; Gisela Vaitaitis; Jessica R Carter; John R Corboy; David H Wagner
Journal:  J Neuroimmunol       Date:  2014-03-15       Impact factor: 3.478

Review 9.  Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis.

Authors:  David H Wagner
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-23       Impact factor: 5.555

Review 10.  CD40 in coronary artery disease: a matter of macrophages?

Authors:  Matthijs F Jansen; Maurits R Hollander; Niels van Royen; Anton J Horrevoets; Esther Lutgens
Journal:  Basic Res Cardiol       Date:  2016-05-04       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.